Found: 140
Select item for more details and to access through your institution.
Oral lichenoid drug eruption due to osimertinib for lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1278, doi. 10.1177/10781552241268693
- By:
- Publication type:
- Article
Neuroblastoma with a Solitary Intraventricular Brain Metastasis Visualized on I-123 MIBG Scan.
- Published in:
- Journal of Neuroimaging, 2014, v. 24, n. 2, p. 202, doi. 10.1111/j.1552-6569.2012.00754.x
- By:
- Publication type:
- Article
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1122, doi. 10.1177/10781552241258175
- By:
- Publication type:
- Article
Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans' affairs medical center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 4, p. 697, doi. 10.1177/10781552231184178
- By:
- Publication type:
- Article
Unusual encephalopathy with Wernicke–Korsakoff syndrome-like features due to adjuvant nivolumab for malignant melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 2, p. 408, doi. 10.1177/10781552231215088
- By:
- Publication type:
- Article
Unusual stroke-like symptoms with oxaliplatin use.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1766, doi. 10.1177/10781552231181525
- By:
- Publication type:
- Article
Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1278, doi. 10.1177/10781552231154460
- By:
- Publication type:
- Article
Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1259, doi. 10.1177/10781552221148973
- By:
- Publication type:
- Article
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1255, doi. 10.1177/10781552221148968
- By:
- Publication type:
- Article
Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 917, doi. 10.1177/10781552221148417
- By:
- Publication type:
- Article
A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström's macroglobulinemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 8, p. 1917, doi. 10.1177/10781552221087730
- By:
- Publication type:
- Article
Cecal volvulus associated with carfilzomib use for al amyloidosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1230, doi. 10.1177/10781552221074719
- By:
- Publication type:
- Article
Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1218, doi. 10.1177/10781552221074025
- By:
- Publication type:
- Article
Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 1003, doi. 10.1177/10781552211073532
- By:
- Publication type:
- Article
Diabetic ketoacidosis as a hallmark of autoimmune diabetes occurring after two cycles of cemiplimab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 722, doi. 10.1177/10781552211060523
- By:
- Publication type:
- Article
Sustained erythrocytosis due to the use of Lenvatinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 475, doi. 10.1177/10781552211039108
- By:
- Publication type:
- Article
Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 442, doi. 10.1177/10781552211029703
- By:
- Publication type:
- Article
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1775, doi. 10.1177/1078155220987616
- By:
- Publication type:
- Article
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 6, p. 1534, doi. 10.1177/1078155220976797
- By:
- Publication type:
- Article
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 5, p. 1181, doi. 10.1177/10781552211015769
- By:
- Publication type:
- Article
Multidirectional pattern of hair growth with carflizomib use for multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 5, p. 1291, doi. 10.1177/1078155220964544
- By:
- Publication type:
- Article
Bluish-gray fingernail discoloration due to the use of nivolumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, p. 457, doi. 10.1177/1078155220929974
- By:
- Publication type:
- Article
Advanced papillary thyroid carcinoma responding to nivolumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, p. 453, doi. 10.1177/1078155220929967
- By:
- Publication type:
- Article
Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 1, p. 205, doi. 10.1177/1078155220975079
- By:
- Publication type:
- Article
Severe terminal ileitis induced by single-agent nivolumab administered every four weeks.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 6, p. 1516, doi. 10.1177/1078155220903367
- By:
- Publication type:
- Article
5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1285, doi. 10.1177/1078155220901769
- By:
- Publication type:
- Article
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 688, doi. 10.1177/1078155219869441
- By:
- Publication type:
- Article
Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1025, doi. 10.1177/1078155219884605
- By:
- Publication type:
- Article
Angioedema late in the course of adjuvant nivolumab therapy for melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1019, doi. 10.1177/1078155219881181
- By:
- Publication type:
- Article
Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: A single-institution retrospective cohort study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1999, doi. 10.1177/1078155219857792
- By:
- Publication type:
- Article
Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2052, doi. 10.1177/1078155219830166
- By:
- Publication type:
- Article
Severe left atrial enlargement due to carfilzomib use in multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2045, doi. 10.1177/1078155218825298
- By:
- Publication type:
- Article
Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2016, doi. 10.1177/1078155218816775
- By:
- Publication type:
- Article
Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1719, doi. 10.1177/1078155219838614
- By:
- Publication type:
- Article
Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1520, doi. 10.1177/1078155218791314
- By:
- Publication type:
- Article
Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1531, doi. 10.1177/1078155218820580
- By:
- Publication type:
- Article
Polymyalgia rheumatica due to pembrolizumab therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 5, p. 1282, doi. 10.1177/1078155218800386
- By:
- Publication type:
- Article
Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1003, doi. 10.1177/1078155218772327
- By:
- Publication type:
- Article
Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 990, doi. 10.1177/1078155218768875
- By:
- Publication type:
- Article
Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 966, doi. 10.1177/1078155218755868
- By:
- Publication type:
- Article
Cystic acne due to imatinib therapy for chronic myelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 972, doi. 10.1177/1078155218761799
- By:
- Publication type:
- Article
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 638, doi. 10.1177/1078155218799850
- By:
- Publication type:
- Article
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 214, doi. 10.1177/1078155218785002
- By:
- Publication type:
- Article
Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 3, p. 229, doi. 10.1177/1078155217698845
- By:
- Publication type:
- Article
Persistent foot ulcer due to ruxolitinib therapy for primary myelofibrosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 3, p. 226, doi. 10.1177/1078155217697488
- By:
- Publication type:
- Article
Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 2, p. 150, doi. 10.1177/1078155217689947
- By:
- Publication type:
- Article
Sustained clinico-radiologic response to anti-cytotoxic T lymphocyte antigen 4 antibody therapy in metastatic myxoid liposarcoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 7, p. 549, doi. 10.1177/1078155216664202
- By:
- Publication type:
- Article
Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 8, p. 638, doi. 10.1177/1078155216674355
- By:
- Publication type:
- Article
Severe phototoxic reaction secondary to subcutaneous 5-azacitidine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 6, p. 473, doi. 10.1177/1078155216660185
- By:
- Publication type:
- Article